EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Flora Growth's enterprise value is $16.88 Mil.
Flora Growth's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-46.43 Mil. Therefore, Flora Growth's EV-to-EBITDA for today is -0.36.
The historical rank and industry rank for Flora Growth's EV-to-EBITDA or its related term are showing as below:
FLGC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -149.33 Med: -1.57 Max: -0.05
Current: -0.36
During the past 5 years, the highest EV-to-EBITDA of Flora Growth was -0.05. The lowest was -149.33. And the median was -1.57.
FLGC's EV-to-EBITDA is ranked worse than 100% of 708
companies
in the Drug Manufacturers industry
Industry Median: 14.76
vs FLGC: -0.36
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Flora Growth EV-to-EBITDA Historical Data
The historical data trend for Flora Growth's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Flora Growth's EV-to-EBITDA
For the Drug Manufacturers - Specialty & Generic subindustry, Flora Growth's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Flora Growth's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Flora Growth's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Flora Growth's EV-to-EBITDA falls into.
Flora Growth EV-to-EBITDA Calculation
Flora Growth's EV-to-EBITDA for today is calculated as:
Flora Growth's current Enterprise Value is $16.88 Mil.
Flora Growth's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-46.43 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Flora Growth (NAS:FLGC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Flora Growth's PE Ratio for today is calculated as:
Flora Growth's share price for today is $1.37.
Flora Growth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.840.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Flora Growth's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company operates in the United States, Germany, Colombia, the United Kingdom, and Canada. it derives a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FLGC has been successfully added to your 